NYSE:CBT - New York Stock Exchange, Inc. - US1270551013 - Common Stock - Currency: USD
84.47
-1.04 (-1.22%)
The current stock price of CBT is 84.47 USD. In the past month the price decreased by -5.53%. In the past year, price increased by 1.66%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
DOW | DOW INC | 23.11 | 27.81B | ||
LYB | LYONDELLBASELL INDU-CL A | 12.02 | 24.94B | ||
WLK | WESTLAKE CORP | 18.69 | 14.12B | ||
OLN | OLIN CORP | 22.96 | 3.11B | ||
MEOH | METHANEX CORP | 11.9 | 2.98B | ||
PCTTU | PURECYCLE TECHNOLOGIES INC | N/A | 2.31B | ||
HWKN | HAWKINS INC | 26.57 | 2.19B | ||
BAK | BRASKEM SA-CLASS A- ADR | N/A | 1.76B | ||
PCT | PURECYCLE TECHNOLOGIES INC | N/A | 1.75B | ||
TROX | TRONOX HOLDINGS PLC | N/A | 1.24B | ||
KRO | KRONOS WORLDWIDE INC | 35.04 | 1.01B | ||
OEC | ORION SA | 8.62 | 870.99M |
Cabot Corp. is a global specialty chemicals and performance materials company. The company is headquartered in Boston, Massachusetts. The firm operates through two segments: Reinforcement Materials and Performance Chemicals. The Reinforcement Materials segment combines reinforcing carbons, engineered elastomer composites and EVOLVE Sustainable Solutions product. The reinforcing carbons products are used in tires and industrial products. In Performance Chemicals, it designs, manufacture and sell materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy. The Performance Chemicals segment combine specialty carbons, specialty compounds, battery materials, fumed metal oxides, aerogel and inkjet product lines. Its products include Carbon black, specialty carbons, battery materials, fumed silica, aerogel and inkjet colorants.
CABOT CORP
Two Seaport Lane Suite 1400
Boston MASSACHUSETTS 02210 US
CEO: Sean D. Keohane
Employees: 4268
Company Website: https://www.cabotcorp.com/
Investor Relations: https://investor.cabot-corp.com
Phone: 16173450100
The current stock price of CBT is 84.47 USD. The price decreased by -1.22% in the last trading session.
The exchange symbol of CABOT CORP is CBT and it is listed on the New York Stock Exchange, Inc. exchange.
CBT stock is listed on the New York Stock Exchange, Inc. exchange.
9 analysts have analysed CBT and the average price target is 114.75 USD. This implies a price increase of 35.85% is expected in the next year compared to the current price of 84.47. Check the CABOT CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CABOT CORP (CBT) has a market capitalization of 4.58B USD. This makes CBT a Mid Cap stock.
CABOT CORP (CBT) currently has 4268 employees.
CABOT CORP (CBT) has a support level at 84.46 and a resistance level at 86.33. Check the full technical report for a detailed analysis of CBT support and resistance levels.
The Revenue of CABOT CORP (CBT) is expected to grow by 2.94% in the next year. Check the estimates tab for more information on the CBT EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CABOT CORP (CBT) has a dividend yield of 2%. The yearly dividend amount is currently 1.7. Check the full fundamental report for a detailed analysis of CBT dividend history, reliability and sustainability.
CABOT CORP (CBT) will report earnings on 2025-05-05, after the market close.
The PE ratio for CABOT CORP (CBT) is 11.63. This is based on the reported non-GAAP earnings per share of 7.26 and the current share price of 84.47 USD. Check the full fundamental report for a full analysis of the valuation metrics for CBT.
The outstanding short interest for CABOT CORP (CBT) is 4.28% of its float. Check the ownership tab for more information on the CBT short interest.
ChartMill assigns a fundamental rating of 7 / 10 to CBT. CBT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months CBT reported a non-GAAP Earnings per Share(EPS) of 7.26. The EPS increased by 21.81% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.45% | ||
ROA | 11.45% | ||
ROE | 30.53% | ||
Debt/Equity | 0.87 |
ChartMill assigns a Buy % Consensus number of 73% to CBT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 7.83% and a revenue growth 2.94% for CBT